nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—PLA2G4A—Epirubicin—stomach cancer	0.466	1	CbGbCtD
Suramin—F2—hepatic artery—stomach cancer	0.0269	0.123	CbGeAlD
Suramin—F2—portal vein—stomach cancer	0.0233	0.107	CbGeAlD
Suramin—F2—vein—stomach cancer	0.0134	0.0616	CbGeAlD
Suramin—P2RY2—hematopoietic system—stomach cancer	0.00838	0.0385	CbGeAlD
Suramin—SIRT1—blood vessel—stomach cancer	0.00806	0.037	CbGeAlD
Suramin—P2RY2—epithelium—stomach cancer	0.00766	0.0352	CbGeAlD
Suramin—PLA2G4A—Raltitrexed—Methotrexate—stomach cancer	0.00493	1	CbGdCrCtD
Suramin—P2RX4—hematopoietic system—stomach cancer	0.0049	0.0225	CbGeAlD
Suramin—P2RY2—endocrine gland—stomach cancer	0.00482	0.0221	CbGeAlD
Suramin—FSHR—endocrine gland—stomach cancer	0.00453	0.0208	CbGeAlD
Suramin—SIRT1—hematopoietic system—stomach cancer	0.00429	0.0197	CbGeAlD
Suramin—F2—blood vessel—stomach cancer	0.00426	0.0196	CbGeAlD
Suramin—ARSA—hematopoietic system—stomach cancer	0.00424	0.0195	CbGeAlD
Suramin—F2—gall bladder—stomach cancer	0.00401	0.0184	CbGeAlD
Suramin—SIRT1—epithelium—stomach cancer	0.00392	0.018	CbGeAlD
Suramin—SIRT1—pancreas—stomach cancer	0.00349	0.016	CbGeAlD
Suramin—RYR1—smooth muscle tissue—stomach cancer	0.00349	0.016	CbGeAlD
Suramin—P2RX4—bone marrow—stomach cancer	0.00314	0.0144	CbGeAlD
Suramin—SIRT1—lymphoid tissue—stomach cancer	0.00302	0.0139	CbGeAlD
Suramin—PLA2G2A—hematopoietic system—stomach cancer	0.003	0.0138	CbGeAlD
Suramin—SIRT1—digestive system—stomach cancer	0.00298	0.0137	CbGeAlD
Suramin—ARSA—lymphoid tissue—stomach cancer	0.00298	0.0137	CbGeAlD
Suramin—SIRT5—endocrine gland—stomach cancer	0.00298	0.0137	CbGeAlD
Suramin—ARSA—digestive system—stomach cancer	0.00295	0.0135	CbGeAlD
Suramin—P2RX4—endocrine gland—stomach cancer	0.00281	0.0129	CbGeAlD
Suramin—SIRT1—bone marrow—stomach cancer	0.00275	0.0126	CbGeAlD
Suramin—PLA2G2A—epithelium—stomach cancer	0.00275	0.0126	CbGeAlD
Suramin—SIRT5—liver—stomach cancer	0.00268	0.0123	CbGeAlD
Suramin—PLA2G2A—smooth muscle tissue—stomach cancer	0.00265	0.0122	CbGeAlD
Suramin—P2RX4—liver—stomach cancer	0.00254	0.0116	CbGeAlD
Suramin—SIRT1—endocrine gland—stomach cancer	0.00247	0.0113	CbGeAlD
Suramin—PLA2G2A—pancreas—stomach cancer	0.00245	0.0112	CbGeAlD
Suramin—ARSA—endocrine gland—stomach cancer	0.00244	0.0112	CbGeAlD
Suramin—RYR1—endocrine gland—stomach cancer	0.00228	0.0105	CbGeAlD
Suramin—F2—hematopoietic system—stomach cancer	0.00227	0.0104	CbGeAlD
Suramin—SIRT1—liver—stomach cancer	0.00222	0.0102	CbGeAlD
Suramin—ARSA—liver—stomach cancer	0.0022	0.0101	CbGeAlD
Suramin—PLA2G2A—lymphoid tissue—stomach cancer	0.00212	0.00971	CbGeAlD
Suramin—PLA2G2A—digestive system—stomach cancer	0.00209	0.00959	CbGeAlD
Suramin—PLA2G4A—hematopoietic system—stomach cancer	0.00209	0.00959	CbGeAlD
Suramin—F2—epithelium—stomach cancer	0.00207	0.00952	CbGeAlD
Suramin—SIRT5—lymph node—stomach cancer	0.00206	0.00945	CbGeAlD
Suramin—RYR1—liver—stomach cancer	0.00205	0.00943	CbGeAlD
Suramin—P2RX4—lymph node—stomach cancer	0.00195	0.00893	CbGeAlD
Suramin—PLA2G4A—smooth muscle tissue—stomach cancer	0.00184	0.00845	CbGeAlD
Suramin—PLA2G2A—endocrine gland—stomach cancer	0.00173	0.00793	CbGeAlD
Suramin—SIRT1—lymph node—stomach cancer	0.0017	0.00783	CbGeAlD
Suramin—ARSA—lymph node—stomach cancer	0.00168	0.00773	CbGeAlD
Suramin—F2—lymphoid tissue—stomach cancer	0.0016	0.00733	CbGeAlD
Suramin—F2—digestive system—stomach cancer	0.00158	0.00724	CbGeAlD
Suramin—PLA2G2A—liver—stomach cancer	0.00156	0.00715	CbGeAlD
Suramin—F2—bone marrow—stomach cancer	0.00145	0.00668	CbGeAlD
Suramin—PLA2G4A—bone marrow—stomach cancer	0.00134	0.00615	CbGeAlD
Suramin—F2—endocrine gland—stomach cancer	0.0013	0.00599	CbGeAlD
Suramin—PLA2G4A—endocrine gland—stomach cancer	0.0012	0.00551	CbGeAlD
Suramin—PLA2G2A—lymph node—stomach cancer	0.00119	0.00548	CbGeAlD
Suramin—F2—liver—stomach cancer	0.00118	0.0054	CbGeAlD
Suramin—PLA2G4A—lymph node—stomach cancer	0.00083	0.00381	CbGeAlD
Suramin—FSHR—Signaling Pathways—NOS3—stomach cancer	3.29e-05	0.000106	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HBEGF—stomach cancer	3.28e-05	0.000105	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—PIK3CA—stomach cancer	3.25e-05	0.000104	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—MTHFR—stomach cancer	3.24e-05	0.000104	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RGS2—stomach cancer	3.24e-05	0.000104	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GAST—stomach cancer	3.24e-05	0.000104	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	3.22e-05	0.000103	CbGpPWpGaD
Suramin—ARSA—Metabolism—PTGS2—stomach cancer	3.21e-05	0.000103	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	3.21e-05	0.000103	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—ERBB2—stomach cancer	3.19e-05	0.000102	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.16e-05	0.000102	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.16e-05	0.000101	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	3.14e-05	0.000101	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—PIK3CA—stomach cancer	3.14e-05	0.000101	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ALOX5—stomach cancer	3.12e-05	0.0001	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	3.12e-05	0.0001	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—ERBB2—stomach cancer	3.08e-05	9.88e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—DPYD—stomach cancer	3.07e-05	9.85e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FST—stomach cancer	3.07e-05	9.84e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FGG—stomach cancer	3.07e-05	9.84e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—ADRB2—stomach cancer	3.03e-05	9.72e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CXCL8—stomach cancer	3.02e-05	9.7e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—SERPINE1—stomach cancer	3.01e-05	9.66e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—HRAS—stomach cancer	3e-05	9.64e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—ALB—stomach cancer	3e-05	9.64e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HBEGF—stomach cancer	3e-05	9.63e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CAV1—stomach cancer	2.99e-05	9.6e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—APOA1—stomach cancer	2.98e-05	9.57e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PPP2R1A—stomach cancer	2.97e-05	9.52e-05	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	2.97e-05	9.52e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RGS2—stomach cancer	2.96e-05	9.5e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GAST—stomach cancer	2.96e-05	9.5e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CDKN1B—stomach cancer	2.95e-05	9.47e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PRKAA1—stomach cancer	2.95e-05	9.47e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CXCL8—stomach cancer	2.92e-05	9.37e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—RHOA—stomach cancer	2.9e-05	9.31e-05	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—HRAS—stomach cancer	2.9e-05	9.31e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—IL6—stomach cancer	2.87e-05	9.23e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—NOS3—stomach cancer	2.87e-05	9.22e-05	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	2.87e-05	9.2e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.86e-05	9.17e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RBP4—stomach cancer	2.85e-05	9.15e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CDKN1B—stomach cancer	2.85e-05	9.15e-05	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CXCL8—stomach cancer	2.85e-05	9.14e-05	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	2.84e-05	9.11e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CCND1—stomach cancer	2.82e-05	9.04e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—JUN—stomach cancer	2.81e-05	9.02e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FGG—stomach cancer	2.81e-05	9e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.78e-05	8.92e-05	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—IL6—stomach cancer	2.78e-05	8.91e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—ADRB2—stomach cancer	2.77e-05	8.89e-05	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—MAPK3—stomach cancer	2.76e-05	8.85e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—SERPINE1—stomach cancer	2.75e-05	8.83e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—ALB—stomach cancer	2.75e-05	8.81e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MMP9—stomach cancer	2.73e-05	8.77e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CDKN1A—stomach cancer	2.72e-05	8.74e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CCND1—stomach cancer	2.72e-05	8.73e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—JUN—stomach cancer	2.71e-05	8.71e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PPP2R1A—stomach cancer	2.71e-05	8.71e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GSTT1—stomach cancer	2.71e-05	8.71e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PRKAA1—stomach cancer	2.7e-05	8.67e-05	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—MYC—stomach cancer	2.68e-05	8.61e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CYP2A6—stomach cancer	2.68e-05	8.61e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MAPK8—stomach cancer	2.66e-05	8.53e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—RHOA—stomach cancer	2.65e-05	8.52e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MMP9—stomach cancer	2.64e-05	8.47e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CDKN1A—stomach cancer	2.63e-05	8.44e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PPARG—stomach cancer	2.63e-05	8.44e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—NOS3—stomach cancer	2.63e-05	8.43e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—AKR1C3—stomach cancer	2.61e-05	8.37e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RBP4—stomach cancer	2.61e-05	8.37e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MAPK8—stomach cancer	2.57e-05	8.24e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ENO1—stomach cancer	2.54e-05	8.16e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.5e-05	8.02e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—VEGFA—stomach cancer	2.46e-05	7.88e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AGTR2—stomach cancer	2.45e-05	7.87e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HSPB1—stomach cancer	2.45e-05	7.87e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—STAT3—stomach cancer	2.43e-05	7.8e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—F2R—stomach cancer	2.42e-05	7.78e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—BMP2—stomach cancer	2.42e-05	7.78e-05	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—MMP2—stomach cancer	2.41e-05	7.74e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AKR1C3—stomach cancer	2.39e-05	7.65e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—VEGFA—stomach cancer	2.37e-05	7.61e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ALB—stomach cancer	2.36e-05	7.58e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HTR1A—stomach cancer	2.36e-05	7.57e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—STAT3—stomach cancer	2.35e-05	7.53e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MAPK3—stomach cancer	2.32e-05	7.45e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—PRKCB—stomach cancer	2.29e-05	7.33e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ANXA1—stomach cancer	2.28e-05	7.31e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—NOS3—stomach cancer	2.26e-05	7.26e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MYC—stomach cancer	2.26e-05	7.25e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CD44—stomach cancer	2.25e-05	7.24e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MAPK3—stomach cancer	2.24e-05	7.2e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HSPB1—stomach cancer	2.24e-05	7.2e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AGTR2—stomach cancer	2.24e-05	7.2e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—F2R—stomach cancer	2.22e-05	7.12e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—BMP2—stomach cancer	2.22e-05	7.12e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MAPK1—stomach cancer	2.21e-05	7.09e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—EGFR—stomach cancer	2.21e-05	7.09e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ADRB1—stomach cancer	2.21e-05	7.08e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.19e-05	7.02e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MYC—stomach cancer	2.18e-05	7e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AKR1C3—stomach cancer	2.18e-05	7e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HTR1A—stomach cancer	2.16e-05	6.93e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MAPK1—stomach cancer	2.13e-05	6.85e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—EGFR—stomach cancer	2.13e-05	6.85e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RPS6—stomach cancer	2.11e-05	6.77e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—KRAS—stomach cancer	2.09e-05	6.7e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ANXA1—stomach cancer	2.08e-05	6.69e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PRKCB—stomach cancer	2.08e-05	6.66e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—VEGFA—stomach cancer	2.07e-05	6.64e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PTGS2—stomach cancer	2.07e-05	6.64e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—IL6ST—stomach cancer	2.07e-05	6.63e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ADRB1—stomach cancer	2.02e-05	6.48e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—KRAS—stomach cancer	2.02e-05	6.47e-05	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—CXCL8—stomach cancer	2e-05	6.43e-05	CbGpPWpGaD
Suramin—ARSA—Metabolism—PIK3CA—stomach cancer	1.97e-05	6.34e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—MAPK3—stomach cancer	1.96e-05	6.28e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HBEGF—stomach cancer	1.94e-05	6.22e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RPS6—stomach cancer	1.93e-05	6.19e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PIK3CA—stomach cancer	1.92e-05	6.15e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PPP2R1A—stomach cancer	1.92e-05	6.15e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PRKCB—stomach cancer	1.9e-05	6.09e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—VEGFA—stomach cancer	1.89e-05	6.07e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—IL6ST—stomach cancer	1.89e-05	6.07e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GSTP1—stomach cancer	1.88e-05	6.04e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—MAPK1—stomach cancer	1.86e-05	5.98e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TP53—stomach cancer	1.86e-05	5.95e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—HMOX1—stomach cancer	1.85e-05	5.95e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PIK3CA—stomach cancer	1.85e-05	5.94e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—IL6R—stomach cancer	1.84e-05	5.92e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—RHOA—stomach cancer	1.83e-05	5.89e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TP53—stomach cancer	1.79e-05	5.75e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—MAPK3—stomach cancer	1.79e-05	5.75e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ADRB2—stomach cancer	1.79e-05	5.74e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HRAS—stomach cancer	1.77e-05	5.69e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HBEGF—stomach cancer	1.77e-05	5.69e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—KRAS—stomach cancer	1.76e-05	5.65e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PPP2R1A—stomach cancer	1.75e-05	5.62e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—TYMS—stomach cancer	1.75e-05	5.61e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GSTM1—stomach cancer	1.73e-05	5.55e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HRAS—stomach cancer	1.71e-05	5.5e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—MAPK1—stomach cancer	1.7e-05	5.47e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IL6—stomach cancer	1.7e-05	5.45e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—IL6R—stomach cancer	1.69e-05	5.41e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—RHOA—stomach cancer	1.67e-05	5.35e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IL6—stomach cancer	1.64e-05	5.26e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ADRB2—stomach cancer	1.64e-05	5.25e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SMAD4—stomach cancer	1.63e-05	5.22e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ERCC2—stomach cancer	1.62e-05	5.21e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—PIK3CA—stomach cancer	1.62e-05	5.19e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CXCL8—stomach cancer	1.61e-05	5.17e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—KRAS—stomach cancer	1.61e-05	5.16e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PPP2R1A—stomach cancer	1.6e-05	5.14e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—TP53—stomach cancer	1.56e-05	5.02e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FYN—stomach cancer	1.55e-05	4.96e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—MTHFR—stomach cancer	1.53e-05	4.9e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—RHOA—stomach cancer	1.52e-05	4.89e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—HRAS—stomach cancer	1.5e-05	4.8e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SMAD4—stomach cancer	1.49e-05	4.78e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—PIK3CA—stomach cancer	1.48e-05	4.74e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CXCL8—stomach cancer	1.46e-05	4.69e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FGFR2—stomach cancer	1.45e-05	4.66e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TP53—stomach cancer	1.43e-05	4.59e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FYN—stomach cancer	1.41e-05	4.54e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CAV1—stomach cancer	1.41e-05	4.52e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—APOA1—stomach cancer	1.41e-05	4.51e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—HRAS—stomach cancer	1.37e-05	4.39e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.35e-05	4.32e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CXCL8—stomach cancer	1.34e-05	4.29e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IRS2—stomach cancer	1.33e-05	4.26e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FGFR2—stomach cancer	1.33e-05	4.26e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CAV1—stomach cancer	1.29e-05	4.13e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—APOA1—stomach cancer	1.29e-05	4.12e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PIK3CA—stomach cancer	1.27e-05	4.08e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PPARG—stomach cancer	1.24e-05	3.97e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PRKCB—stomach cancer	1.23e-05	3.93e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IL6ST—stomach cancer	1.22e-05	3.92e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IRS2—stomach cancer	1.21e-05	3.9e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CAV1—stomach cancer	1.18e-05	3.78e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—APOA1—stomach cancer	1.18e-05	3.77e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—APC—stomach cancer	1.17e-05	3.76e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—MAPK3—stomach cancer	1.12e-05	3.61e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PRKCB—stomach cancer	1.12e-05	3.6e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IL6ST—stomach cancer	1.12e-05	3.58e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ALB—stomach cancer	1.11e-05	3.57e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IL6R—stomach cancer	1.09e-05	3.5e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—APC—stomach cancer	1.07e-05	3.44e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—MAPK1—stomach cancer	1.07e-05	3.43e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—EGFR—stomach cancer	1.07e-05	3.43e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—NOS3—stomach cancer	1.07e-05	3.42e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—MAPK3—stomach cancer	1.03e-05	3.3e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—PIK3CA—stomach cancer	1.02e-05	3.28e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SERPINE1—stomach cancer	1.02e-05	3.27e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—KRAS—stomach cancer	1.01e-05	3.24e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IL6R—stomach cancer	9.96e-06	3.2e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RHOA—stomach cancer	9.84e-06	3.16e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—MAPK1—stomach cancer	9.78e-06	3.14e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—EGFR—stomach cancer	9.78e-06	3.14e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PTGS2—stomach cancer	9.74e-06	3.13e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NOS3—stomach cancer	9.74e-06	3.13e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SERPINE1—stomach cancer	9.33e-06	2.99e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PIK3CA—stomach cancer	9.28e-06	2.98e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—KRAS—stomach cancer	9.24e-06	2.96e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ERBB2—stomach cancer	9.11e-06	2.92e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RHOA—stomach cancer	9e-06	2.89e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NOS3—stomach cancer	8.91e-06	2.86e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CXCL8—stomach cancer	8.64e-06	2.77e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HRAS—stomach cancer	8.58e-06	2.75e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PIK3CA—stomach cancer	8.48e-06	2.72e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CDKN1B—stomach cancer	8.44e-06	2.71e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ERBB2—stomach cancer	8.33e-06	2.67e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—IL6—stomach cancer	8.21e-06	2.64e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCND1—stomach cancer	8.05e-06	2.58e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—JUN—stomach cancer	8.03e-06	2.58e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CXCL8—stomach cancer	7.9e-06	2.54e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HRAS—stomach cancer	7.85e-06	2.52e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MMP9—stomach cancer	7.81e-06	2.51e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CDKN1A—stomach cancer	7.79e-06	2.5e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CDKN1B—stomach cancer	7.72e-06	2.48e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MAPK8—stomach cancer	7.6e-06	2.44e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—IL6—stomach cancer	7.51e-06	2.41e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCND1—stomach cancer	7.36e-06	2.36e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—JUN—stomach cancer	7.35e-06	2.36e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MMP9—stomach cancer	7.15e-06	2.29e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CDKN1A—stomach cancer	7.12e-06	2.29e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—VEGFA—stomach cancer	7.02e-06	2.25e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MAPK8—stomach cancer	6.95e-06	2.23e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—STAT3—stomach cancer	6.95e-06	2.23e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MAPK3—stomach cancer	6.64e-06	2.13e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MYC—stomach cancer	6.46e-06	2.07e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—VEGFA—stomach cancer	6.42e-06	2.06e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—STAT3—stomach cancer	6.35e-06	2.04e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MAPK1—stomach cancer	6.32e-06	2.03e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—EGFR—stomach cancer	6.31e-06	2.03e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MAPK3—stomach cancer	6.07e-06	1.95e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PIK3CA—stomach cancer	5.99e-06	1.92e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—KRAS—stomach cancer	5.96e-06	1.91e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MYC—stomach cancer	5.9e-06	1.89e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MAPK1—stomach cancer	5.78e-06	1.85e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—EGFR—stomach cancer	5.78e-06	1.85e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PIK3CA—stomach cancer	5.48e-06	1.76e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—KRAS—stomach cancer	5.46e-06	1.75e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TP53—stomach cancer	5.3e-06	1.7e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HRAS—stomach cancer	5.07e-06	1.63e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PIK3CA—stomach cancer	5.01e-06	1.61e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IL6—stomach cancer	4.85e-06	1.56e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TP53—stomach cancer	4.85e-06	1.56e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HRAS—stomach cancer	4.64e-06	1.49e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IL6—stomach cancer	4.44e-06	1.42e-05	CbGpPWpGaD
